PT - JOURNAL ARTICLE AU - Olin, Axel AU - Jaquaniello, Anthony AU - Roux, Maguelonne AU - Tan, Ziyang AU - Pou, Christian AU - Dubois, Florian AU - Charbit, Bruno AU - Liu, Dang AU - Bloch, Emma AU - Clave, Emmanuel AU - Araujo, Itauá Leston AU - Toubert, Antoine AU - White, Michael AU - Rotival, Maxime AU - Brodin, Petter AU - Duffy, Darragh AU - Quintana-Murci, Lluis AU - Patin, Etienne AU - Milieu Intérieur Consortium TI - Demographic and genetic factors shape the epitope specificity of the human antibody repertoire against viruses AID - 10.1101/2023.11.07.23298153 DP - 2024 Jan 01 TA - medRxiv PG - 2023.11.07.23298153 4099 - http://medrxiv.org/content/early/2024/11/20/2023.11.07.23298153.short 4100 - http://medrxiv.org/content/early/2024/11/20/2023.11.07.23298153.full AB - Antibodies are central to immune defenses. Despite advances in understanding the mechanisms of antibody generation, a comprehensive model of how intrinsic and external factors shape human humoral responses to viruses is lacking. Here, we apply PhIP-Seq to investigate the effects of demographic and genetic factors on antibody reactivity to more than 97,000 viral peptides in 1,212 healthy adults. We demonstrate that age, sex, and continent of birth extensively influence the viruses and viral epitopes targeted by the human antibody repertoire. Among 108 lifestyle and health-related variables, smoking exerts the strongest, yet reversible, impact on antibody profiles, primarily against rhinoviruses. Additionally, we identify strong associations between antibodies against 34 viruses and genetic variants at HLA, FUT2, IGH, and IGK genes, some of which increase autoimmune disease risk. These findings offer a valuable resource for understanding the factors affecting antibody-mediated immunity, laying the groundwork for optimizing vaccine strategies.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.milieuinterieur.fr/en/ Funding StatementThe study received funding from the Wenner-Gren Foundation and benefited from the support of the French government program Investissement d'Avenir, managed by the Agence Nationale de la Recherche (reference 10-LABX-69-01).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institut Pasteur (Pasteur ID-RCB Number:2012-A00238-35), the Comités de Protection des Personnes, Ouest 6 and Sud Méditerranée (CPP), the Agence Nationale de Sécurité du Médicament (ANSM) and the Commission nationale de l'informatique et des libertés (CNIL) gave ethical approval for the Milieu Intérieur clinical study and this work. The ethics committee of Ghent University (B670201214647), the Ethics Board of Institut Pasteur (EVOIMMUNOPOP-281297), the Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé (CCITRS), the CPP and the CNIL gave ethical approval for the EvoImmunoPop study and this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe VirScan3 PhIP-seq raw and processed data generated in this study have been deposited in the Institut Pasteur data repository, OWEY, which can be accessed via the following link: https://dataset.owey.io/doi/10.48802/owey.84rn-jg72?version=1.1. All association statistics obtained in this study can be explored and downloaded from the web browser http://mirepertoire.pasteur.cloud/. The SNP array data can be accessed in the European Genome-Phenome Archive (EGA) with the accession code EGAS00001002460. All Milieu Intérieur datasets can be accessed by submitting a data access request to milieuinterieurdac{at}pasteur.fr, the Milieu Intérieur data access committee (DAC). The DAC informs all the research participants of the data access request and grants data access if the request is consistent with the informed consent signed by the participants. In particular, research on Milieu Intérieur datasets is restricted to research on the genetic and environmental determinants of human variation in immune responses. Data access is typically granted two months after request submission.